Newsletter | February 28, 2026
FEATURED EDITORIAL
At JP Morgan 2026, Few Showed Up For U.S. Manufacturing
By Louis Garguilo, chief editor, Outsourced Pharma
Leveraging Conventional Therapeutics Skills For Cell And Gene Therapy
By Geethashri Ananda Ph.D., University of Pittsburgh
From Biology Grad To Manufacturing Guru
Real-World Phase-Appropriate Control Lessons For mAb/ADC Manufacturers
By Victor Lien, Ph.D., PMP
End-To-End ADC Manufacturing Works Best With Active Sponsor Oversight
By Jeffrey S. Buguliskis, Ph.D., deputy chief editor, Outsourced Pharma
Process Engineering's Key Role In Sterile Injectable Facility Design
By Sanjeev Kumar, NIRAS A/S, Denmark
The Top 10 Nations Redrawing The Outsourcing Map
This Industrial Fungus Has Protein Expression Promise For Pharma
A conversation with Antti Aalto, Ph.D., VTT Technical Research Centre of Finland
The Quiet Case For Trusting CDMO Pricing
What To Know About — And How To Apply For — FDA's PreCheck Pilot
By Kalie E. Richardson, Hyman, Phelps & McNamara
INDUSTRY INSIGHTS
3 Keys To Success When Planning With Your CMO Partner
Argonaut Manufacturing Services
A Bridge To The Future: Our World-Class Site In Bridgeton
Kindeva
Developability Assessment And Early Formulation Studies
Coriolis Pharma
End-To-End Biologics Support
Curia
Expert Insights On Outsourcing In A Dynamic Biopharma Landscape
By Ryan Lee and Kangsoo Lee, Samsung Biologics
Liposomes — Challenges And Opportunities
Pfizer CentreOne
Can Your Cleaning And Monitoring Withstand Regulatory Scrutiny?
Eurofins
Why The Latest E2500-25 Standard Revision Demands Immediate Action
CAI
Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs
Lonza
Flow Chemistry For Contemporary Isotope Labeling
By Mounir Raji, X-Chem
Achieve Speed, Stability, And Compliance In Cell Line Development
By Séverine Fagète, Ph.D., KBI Biopharma
Optimizing Bispecific Antibody Expression
Asimov
Accelerating A Complex Molecule From CLD To cGMP In 12 Months
Avid Bioservices
FDA's Regenerative Medicine Advanced Therapy (RMAT) Program
By Isaiah Manoogian, Pace Life Sciences
CDMO Trends Impacting 2026
Vector BioMed
Intelligent mRNA Manufacturing Through Process Analytical Technologies
Recipharm Advanced Bio
From Promise To Patients: Pathways To Scale In CGT Manufacturing
By Jennifer Cannon, Thermo Fisher Scientific
Advancing Scalable Vector Production For AAV-Based Treatments
By A. Lennon, M. Fujinobu, A. Dooner, et al., Minaris Advanced Therapies
Managing Cell Therapy Investigational New Drug (IND) Timeline Risks
Kincell Bio
Leveraging Technology For Rapid Clinical Material Delivery
Andelyn Biosciences
Balancing Early-Stage Needs With Future Success
By Omar Baez, Comprehensive Cell Solutions
Enhancing AAV6 Vector Production For Cell Therapies
By Maria Iglesias, Ana Barbas, and César Trigueros, Viralgen
Mastering Ophthalmic Drug Formulation And Testing
Altasciences
A Smarter Way To Elevate Micronization Output
Grace Fine Chemical Manufacturing Services
An Equitable Way To Meet On-Site Business Needs
Redefining OSD Development Through Foresight And Innovation
Thermo Fisher Scientific
Cleaner Chemistry For Faster, Higher‑Quality Peptide Production
The Principles Of Green Chemistry: Design For Energy Efficiency
SK pharmteco
Tailoring Formulations To Meet Precision‑Medicine Needs
Experic
Bioequivalence In Topical Generics: Regulatory Considerations
By Charles Evans, Marc Brown, and Jon Lenn, MedPharm
Advanced, Tailored ADC Solutions
LOTTE Biologics
Efficient Development Of Biologics
ProBio
mRNA Vaccines And Therapeutics: Current Trends And Perspectives
Cytiva
Benefits Of Outsourcing To An Integrated CDMO
MilliporeSigma
Pharma Outsourcing Goes Green
Simtra BioPharma Solutions
Periodic Counter Current Chromatography: A Step Toward Continuous DSP
By Antonio Ginés García Saura and Ingrid Long, AGC Biologics
CDMOs - Key Collaborators In Streamlining Drug Development
Building Bioanalysis Infrastructure For Modern Drug Development
By Ander Tallett, Dash Bio
Streamline Biopharmaceutical Manufacturing With Versatile Platforms
IDT Biologika
3 Keys To Drug Discovery Success — Foresight, Hindsight, And Insight
Labcorp Drug Discovery Solutions
N-1 Perfusion Strategies For Commercial-Ready Biologics
Boehringer Ingelheim Biopharmaceuticals GmbH
Global Reach, Biotech Speed: Clinical Packaging, Labeling That Delivers
FIH: Reach Milestones Sooner With A Technology-Driven Approach
Optimizing CMO Partnerships
SMC Ltd.
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept
By Andreas Reichl, M.D. and Kevin Schaab, Ph.D., Quotient Sciences
Overcoming Manufacturing Challenges For Accelerated Drug Development
Catalent
Mastering Modern Challenges Through Expert Technology Transfer
What Biotechs Should Look For In A CDMO Partner Pre-Commercialization
Mikart
Layer By Layer: 3D Screen Printing And The Future Of Drug Development
By Steven Facer and Klaus Kuhne, Adare Pharma Solutions
How To Approach Brazil's Regulatory Compliance
Reducing Wastewater Incineration And Carbon Emissions
By Dr. Niklaus Künzle and Dr. Andreas Sieber, Lonza
